-
-
-
-
-
-
-
Legend Biotech Corp. (LEGN) PT Lowered to $62 at RBC Capital; 'Shares Should Rebound in 2026'
-
-
-
-
-
-
-
Legend Biotech Corp. (LEGN) PT Lowered to $60 at H.C. Wainwright
-
-
-
-
-
-
-
Legend Biotech Corp. (LEGN) PT Lowered to $71 at Truist Securities
-
-
-
-
-
-
-
Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights
-
-
-
-
-
-
-
Legend Biotech Reports Second Quarter 2024 Results and Recent Highlights
-
-
-
-
-
-
-
Legend Biotech Reports First Quarter 2024 Results and Recent Highlights
-
-
-
-
-
-
-
Legend Biotech to Host Investor Conference Call on Third-Quarter Results
-
1,205,138 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

